Clinical Trial: A Study on the Efficacy of Different Treatment Regimens for IgA Nephropathy and Their Effects on Serum Biomarkers (Gd-IgA1 and sCD89) (China)

Posted On: 2026-10-09

China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy of Different Treatment Regimens for IgA Nephropathy and Their Effects on Serum Biomarkers (Gd-IgA1 and sCD89)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133881

Registration Time: 2026/10/09

Type: Observational study

Primary Sponsor: second hospital of shanxi medical university

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344225

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study on the Efficacy of Different Treatment Regimens for IgA Nephropathy and Their Effects on Serum Biomarkers (Gd-IgA1 and sCD89) (China)